Mr. Speaker, our approach has been to work with the provinces and the drug companies so they can share information about drug shortages publicly on a website.
It was also encouraging that at this year's health ministers meeting, all ministers agreed to work collaboratively on the issue.
We will also continue to monitor whether companies make the information available to doctors and patients and if they do not, then we are open to considering passing regulations requiring them to do so.